NumFin

Shanghai Pharmaceuticals Holding Co., Ltd

符号: SHPMY

PNK

7.41

USD

今天的市场价格

  • 51.8164

    市盈率

  • 0.1005

    PEG比率

  • 7.20B

    MRK市值

  • 0.01%

    DIV收益率

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Shanghai Pharmaceuticals Holding Co., Ltd 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

040669.93701522390.4
22296.2
18152.8
18694.7
14842.7
11970.9
12039.8
11608.6
12978.8
13528.3
14852.7
6341.6
1229.2
1046.4
665.2
564
430.1
522.7
555.3
675.2
587.3
699.2
435.7
258.9
63.2
36.2
30.6
0

balance-sheet.row.short-term-investments

011197.29613.6-1242.8
-1226.3
-1362.9
-1434.9
0.6
4.1
0.8
0.5
0.3
2.9
2.7
3.2
7.3
9.2
35.8
62.5
115.9
92.3
43.1
3.1
50.6
100
0.7
0
0
0
0
0

balance-sheet.row.net-receivables

081003.77663465885.8
59921.7
53944.4
48324.7
35415.5
30982.1
27895.5
23605.7
18170.1
15008.5
12701.1
9322.2
3419.6
2853.3
2751.2
2582.3
2539.6
3002.4
2474.6
1923.1
1615.8
53.1
98.9
92.1
30.2
13.7
19.7
0

balance-sheet.row.inventory

036623.434460.227104
24088.3
24877.4
25024
17270
16415.8
15090.6
13088.2
10996.5
9809.7
8297.5
5040.7
1974.5
1622.8
1364.2
1191.4
1351.1
1223
1370.2
1170
824
610.9
571.3
608.5
125.3
99
73
0

balance-sheet.row.other-current-assets

04136.91403.71114.2
1256.7
1117
1234.5
1114.1
898.2
559.3
355.9
369.6
455.4
144.5
2.7
-121.4
0.1
0.1
15.3
21.5
2.5
0
0
0.3
1329.2
1201.6
1068.6
120.2
95.5
86.4
189.1

balance-sheet.row.total-current-assets

0162433.9149512.9116494.4
107562.9
98091.6
93277.9
68642.3
60266.9
55585.2
48658.3
42515
38801.9
35995.8
20707.2
6502
5522.6
4780.7
4353
4342.2
4750.5
4400.2
3768.3
3027.5
2692.4
2307.5
2028
339
244.4
209.7
189.1

balance-sheet.row.property-plant-equipment-net

018278.716185.315390.7
14220.6
12717.7
10194.6
8691.6
6561.1
5693.4
4993.7
4808.9
4259.4
4039.6
3978.5
892.4
913.5
1129.5
1184.6
979.6
1033.1
1077.1
1058.1
698.4
577.2
511.2
420
217.7
223.6
203
222.3

balance-sheet.row.goodwill

011393.311335.911239
11342.3
10789.9
11345.3
6606.7
5848
4815.6
4473.4
3643.3
3172.8
2988.9
422.8
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

06361.36586.76308.7
5419.1
4142
4283.2
2702.4
2767.1
1984.2
1861.6
1540.3
1406.7
1276.2
875.9
432.5
446.6
526.2
366.1
73.7
143.9
186.1
195.5
183.7
84.7
91.1
96.7
0.3
0.3
0.3
0

balance-sheet.row.goodwill-and-intangible-assets

017754.717922.717547.6
16761.3
14931.9
15628.5
9309.1
8615.1
6799.8
6335
5183.6
4579.5
4265.1
1298.7
432.5
446.6
526.2
366.1
73.7
146.9
186.1
195.5
183.7
84.7
91.1
96.7
0.3
0.3
0.3
0

balance-sheet.row.long-term-investments

011145.31863.611778.3
8888.9
6795.3
6083.4
4802.6
4492.5
3914.6
2932.5
2845.9
2691.4
2634.7
1597.4
277.7
330.2
299.6
701.1
846.5
393.5
404.8
330.4
295.6
36.6
125.2
0
0
0
0
0

balance-sheet.row.tax-assets

01716.91534.71367.5
1359.4
1222.5
1037.9
566.3
468.3
316.3
264.6
199.8
191.7
178.6
150.2
80.3
47.4
29.1
0
0
0
86.6
50.6
88
3.1
-111.6
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0643.111115.7856.9
392.5
3267.5
657.1
2332.6
2338.8
2035
1156.4
758.3
544.9
554
437
944.1
990.4
720.9
73.7
134.1
140.1
86.6
50.6
88
144.4
20.7
66.5
35.6
33.8
36.8
10.3

balance-sheet.row.total-non-current-assets

049538.74862246941.1
41622.7
38934.8
33601.5
25702.2
22475.8
18759
15682.2
13796.5
12267.1
11672
7461.8
2155
2232.9
2344.9
2325.5
2033.8
1713.6
1754.7
1634.5
1265.7
842.9
748.2
583.2
253.6
257.6
240.2
232.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0211972.5198134.9163435.5
149185.7
137026.4
126879.3
94344.5
82742.7
74344.2
64340.6
56311.5
51069
47667.8
28169
8657
7755.5
7125.6
6678.6
6376.1
6464.2
6154.8
5402.8
4293.1
3535.3
3055.6
2611.2
592.5
502.1
449.8
421.8

balance-sheet.row.account-payables

04791551565.541995.4
37792.2
36872.5
35148
27295.2
25985.1
24436.9
20435.9
16875.8
14574.9
12659.5
8667.7
3974.2
3096
2689.7
2061.8
1650.6
1823.1
1534.1
1377.1
965.8
687.8
698.9
718.7
62.2
56.8
36.6
0

balance-sheet.row.short-term-debt

051217.43100023096.6
29107.2
24327.3
22038.7
13803.5
9646.7
10679.3
7953.1
5924.4
4900.8
5675.5
4818.4
1691.1
1919.5
1999.5
2148.3
2309.9
2057.2
1897.7
1511
1131.2
1578
1308.8
984
195.8
188.3
103.1
0

balance-sheet.row.tax-payables

0809.81440.81692.7
1478.1
1215.4
1042.2
1141.4
642.5
612
546.5
393.6
415.9
393.1
254.3
56.8
29
-0.4
19.3
-49.8
-22.7
-16.1
-14.5
6.2
-4.5
-5.7
-10.8
11.5
3.9
0.4
0

balance-sheet.row.long-term-debt-total

05786.27561.48592
2685.1
10289.9
9620.3
2958.8
2836.3
93.4
105.4
125.2
40.8
52.3
66.1
22.1
25.1
3
1.2
103.2
102.1
89.7
30.8
17.5
2.6
1.6
15.6
21.5
33.7
100.7
0

Deferred Revenue Non Current

067.4534.62349.1
2224.1
1278.7
503.3
495.8
589.7
367.9
554.3
0.5
0.5
160.4
156.9
28.1
30.4
32.3
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

021268.86384.99232.4
5018.6
1188.6
2698.4
8533.1
5481.5
4310.4
3613.5
2898.7
2622.4
2521
2431.5
592.8
566.1
437.4
377.7
283.1
392.4
463
444.3
316.3
293.5
196.8
172.8
27.4
34.2
26.4
130.9

balance-sheet.row.total-non-current-liabilities

08708.59441.412545
6311.9
13032.8
11736.3
5036.8
4794.9
1109.6
1238.9
1611.6
1270.1
830.4
367.2
76.4
84.1
40.8
23.8
126.6
130.4
132.6
70.8
61.6
-9.3
1.2
22.3
21.5
33.7
100.7
94.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

01550.11301.61434.3
1501
1155.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0131080.4120132.5104369.3
94444.9
87640.5
80446.1
54668.6
45908.3
40536.2
33241.4
27310.5
23368.2
21686.4
16284.8
6334.6
5665.8
5167.3
4611.7
4370.2
4403.1
4027.4
3403.2
2474.9
2550
2205.7
1897.8
306.9
313
266.9
225.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

03703.33697.52842.1
2842.1
2842.1
2842.1
2688.9
2688.9
2688.9
2688.9
2688.9
2688.9
2688.9
1992.6
569.2
569.2
569.2
474.3
474.3
474.3
474.3
316.2
316.2
229.6
229.6
153
113
58
58
58

balance-sheet.row.retained-earnings

033822.332479.928598.6
25054.4
21970.9
19330.6
16578.3
14138.4
11961
10009.3
8252.6
6718.3
5196.3
3117
437.3
304.1
263
301.1
279
286.7
282.1
168.9
154.9
123.3
32.5
64.9
17.3
0.1
0
16.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

01532.11553.91565.1
1152.1
531.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

029466.429331.716353.7
16306.2
16315
16840.8
14763.6
14795.2
15280.4
15123.9
15012.3
15232.1
15193.3
4024.9
827.1
815.8
809.2
980
1004.3
1002.2
973.4
1074.5
1034.2
441.2
365.8
380.1
155.2
131
125
122.2

balance-sheet.row.total-stockholders-equity

068524.16706349359.5
45354.7
41659.1
39013.6
34030.8
31622.6
29930.3
27822.1
25953.8
24639.3
23078.5
9134.6
1833.5
1689.1
1641.4
1755.5
1757.6
1763.3
1729.8
1559.6
1505.3
794
627.8
598
285.6
189.1
183
196.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0211972.5198134.9163435.5
149185.7
137026.4
126879.3
94344.5
82742.7
74344.2
64340.6
56311.5
51069
47667.8
28169
8657
7755.5
7125.6
6678.6
6376.1
6464.2
6154.8
5402.8
4293.1
3535.3
3055.6
2611.2
592.5
502.1
449.8
421.8

balance-sheet.row.minority-interest

011801.910939.49706.7
9386.1
7726.9
7419.7
5645
5211.9
3877.7
3277
3047.2
3061.6
2903
2749.7
488.9
400.7
316.9
311.5
248.3
297.8
397.7
440
312.9
191.3
222.1
115.5
0
0
0
0

balance-sheet.row.total-equity

080326.178002.559066.2
54740.7
49385.9
46433.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

022342.511477.210535.6
7662.7
5432.4
4648.6
4803.2
4496.6
3915.4
2933
2846.2
2694.4
2637.3
1600.6
285
339.3
335.5
763.6
962.4
485.8
448
333.5
346.2
136.6
125.9
55.6
0.4
0.4
0.9
0

balance-sheet.row.total-debt

058553.638561.431688.6
31792.3
34617.1
31659
16762.3
12483
10772.7
8058.5
6049.6
4941.5
5727.8
4884.5
1713.2
1944.6
2002.4
2149.6
2413.2
2159.3
1987.3
1541.9
1148.6
1580.5
1310.4
999.6
217.3
222
203.8
0

balance-sheet.row.net-debt

029080.9111609298.3
9496.1
16464.3
12964.3
1920.2
516.2
-1266.3
-3549.5
-6928.9
-8583.9
-9122.3
-1453.9
491.3
907.4
1373
1648.1
2099
1728.9
1475.1
869.8
611.9
981.3
875.4
740.7
154.2
185.8
173.2
0

现金流量表

在 Shanghai Pharmaceuticals Holding Co., Ltd 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

0376869926274.6
5605.3
4830.7
4456.3
4057.8
3829.7
3364.4
2992
2626.6
2460.6
2446
1779
263.5
129.4
95.5
90.5
71.4
138.5
207.5
163.1
174.8
204.7
110.8
89.8

cash-flows.row.depreciation-and-amortization

02361.22222.42139.8
2137.8
1885
1169.5
840
746.1
672.6
585
549.7
536.6
479.2
382.7
93.2
94.2
96.4
69.1
59.1
74.2
70.3
72.3
50.4
50.1
43.4
21.4

cash-flows.row.deferred-income-tax

0-194.8-131.9165
-233.9
-217.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-8873.1131.9-165
233.9
217.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-4150.7-4680-3398.7
-2013.7
-2571
-3711.7
-2291.7
-2635.8
-2747.8
-2234.2
-2275.2
-2026.7
-942.8
-368.4
62.9
-104
109.2
298.3
-148.2
-242.3
-230.7
-231
-171.1
-101.2
-61.8
-464.7

cash-flows.row.account-receivables

0-6432.4-10081.4-6155.5
-4072.2
-5083.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-2303.8-7111.7-3201
932.6
63.1
-2842.9
-423
-942.7
-1943.7
-1587
-1179.7
-1466.4
-1565.9
-859.2
-323.3
-270.1
-12.3
153.4
-158.7
71.3
-300
-209.9
-206.2
-39.7
75.8
-509.9

cash-flows.row.account-payables

04585.5126455792.8
1359.7
2667.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-131.9165
-233.9
-217.7
-868.8
-1868.8
-1693.1
-804.2
-647.3
-1095.4
-560.3
623.1
490.8
386.2
166.1
121.5
144.9
10.5
-313.6
69.3
-21.1
35.1
-61.5
-137.6
45.1

cash-flows.row.other-non-cash-items

013303.7208.945.6
1115.4
1877.7
1221.1
42.8
6.7
60.1
-7.1
72.3
180.3
-210
-107.2
244.6
166.1
187.8
125.1
90.7
91.2
-46.6
96.5
11.7
-7.4
72.2
70.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2970.6-2684.9-4118.8
-3010
-2753.1
-1943
-2007.3
-2119.3
-1720.5
-1291.5
-905.1
-708.9
-413.5
-550.3
-80
-90.5
-192.3
-151.6
-198.1
-254.4
-169.6
-279.4
-144.7
-141.1
-52.5
-169.9

cash-flows.row.acquisitions-net

0-116222.5-1039.3
-2045.7
-693.7
-5197.5
-913.6
-1738.7
-602.7
-1083.2
-455.3
-414.2
-4017.5
-2001.5
4
111.2
20.7
218.2
270.2
341.7
176.7
56.5
157.5
142.3
0.2
0

cash-flows.row.purchases-of-investments

0-28423.1-39683.8-3147.8
-4490.9
-1041.4
-1047.6
-4461.3
-2600.6
-1887.9
-707.9
35.8
20.1
41.6
-1325.4
-6.3
-23.2
-13
-22.6
-159.4
-190.1
-344.6
-78.7
-405
-102.3
-175.8
-31.2

cash-flows.row.sales-maturities-of-investments

027986.8302673288.2
4806.1
1271.6
1331.8
5119.4
3099.4
2055.4
976.9
251
179.6
476.3
430.4
36.3
62.1
22.5
108.9
10.3
122.9
102.5
75.4
334.2
122.2
2.1
4.9

cash-flows.row.other-investing-activites

01270.7-394-997.8
3034.8
-1367.7
-836.4
-92.2
469.7
246.6
261.1
216.5
542.3
164.3
703.8
3.9
290.2
9.2
66.6
72.1
87.3
7.1
182.9
12.8
1.2
0.3
-0.1

cash-flows.row.net-cash-used-for-investing-activites

0-3298.2-12473.1-6015.6
-1705.7
-4584.3
-7692.7
-2355
-2889.5
-1908.9
-1844.6
-892.8
-401.3
-3790.4
-2743
-46.1
349.8
-173.6
1.3
-275
-234.2
-404.6
-99.8
-202.7
-120
-225.8
-196.2

cash-flows.row.debt-repayment

0-6855-59808.7-52214.6
-47575.5
-38340.3
-53206.6
-22044.2
-18181.3
-18367.5
-13253.9
-10475.4
-8897.8
-12753.3
-5212.4
-3352.6
-3656.8
-3091.2
-4245.5
-3786.5
-3967.5
-204.2
-289.3
-2536.2
-1871.5
-1822.2
-1445.9

cash-flows.row.common-stock-issued

0000
0
0
2624.8
21.8
905.6
301.4
17.2
35.5
55.1
0
2046.4
6.9
24.3
0
0
0
7.2
0.9
4.5
606.4
0
0
263.2

cash-flows.row.common-stock-repurchased

0000
0
0
60659.6
25613.7
18697.4
19978.7
14169.7
11301.7
7764.4
0
4038.1
3061.5
3581.5
0
0
0
4170.7
595
537.4
1427.5
0
0
1703.9

cash-flows.row.dividends-paid

0-2259-3093.9-2675.9
-2418.4
-2584.2
-2357.8
-1750.2
-1443.5
-1378.2
-1251.6
-1055.4
-891.2
-775.3
-545.6
-136.7
-196
-141.8
-139.2
-210.2
-128.4
-148.3
-122.9
-49.7
-126.5
-50.4
-73

cash-flows.row.other-financing-activites

0-4540.675041.256456.1
48732.6
38598.7
-193.7
26087.3
19366.6
20080.6
13539.5
10773.8
7707.9
24171.7
6037.1
3092.2
3556.4
2897.7
3985.6
4084.9
4177.8
595.9
541.9
2053.9
2135.9
2110.2
1935.8

cash-flows.row.net-cash-used-provided-by-financing-activities

055.412138.61565.6
-1261.2
-2325.8
7526.3
2314.7
647.4
636.4
-948.8
-721.6
-2026
10643.1
2325.4
-390.3
-272.1
-335.3
-399.1
88.3
89.1
244.3
134.2
74.5
137.9
237.5
680

cash-flows.row.effect-of-forex-changes-on-cash

0-5.6-12.4-50.3
-17.6
-1.6
67.4
-18.8
-2.6
10.7
2.8
-14.6
22.7
-280.8
-5.5
0.5
1.4
-1.5
2
-2.5
1.7
0
0
0
0
-0.2
0

cash-flows.row.net-change-in-cash

03152.74396.4561.1
3860.2
-889.3
3036.1
2589.7
-298.1
87.4
-1454.9
-655.5
-1253.8
8344.3
1263.1
228.2
364.9
-21.5
187.3
-116.2
-81.7
-159.9
135.3
-62.5
164.2
176.1
200.6

cash-flows.row.cash-at-end-of-period

029472.724533.920137.5
19576.4
15716.3
16605.6
13569.4
10979.7
11277.9
11190.4
12645.4
13300.9
14554.7
6039.6
1197.7
969.5
607.2
501.5
314.2
430.5
512.2
672.1
536.8
599.2
435
258.9

cash-flows.row.cash-at-beginning-of-period

026320.120137.519576.4
15716.3
16605.6
13569.4
10979.7
11277.9
11190.4
12645.4
13300.9
14554.7
6210.4
4776.5
969.5
604.7
628.7
314.2
430.5
512.2
672.1
536.8
599.2
435
258.9
58.2

cash-flows.row.operating-cash-flow

06214.34743.45061.3
6844.7
6022.4
3135.1
2648.8
1946.7
1349.2
1335.7
973.4
1150.8
1772.4
1686.1
664.1
285.7
488.9
583.1
73
61.7
0.5
100.8
65.7
146.2
164.7
-283.1

cash-flows.row.capital-expenditure

0-2970.6-2684.9-4118.8
-3010
-2753.1
-1943
-2007.3
-2119.3
-1720.5
-1291.5
-905.1
-708.9
-413.5
-550.3
-80
-90.5
-192.3
-151.6
-198.1
-254.4
-169.6
-279.4
-144.7
-141.1
-52.5
-169.9

cash-flows.row.free-cash-flow

03243.72058.5942.6
3834.7
3269.3
1192.1
641.5
-172.6
-371.3
44.2
68.4
441.9
1358.9
1135.8
584.2
195.2
296.7
431.5
-125.1
-192.7
-169.1
-178.6
-79
5.1
112.2
-453

利润表行

Shanghai Pharmaceuticals Holding Co., Ltd 的收入与上期相比变化了 NaN%。据报告, SHPMY 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

income-statement-row.row.total-revenue

0259557231981.3215824.3
191909.2
186565.8
159084.4
130847.2
120764.7
105516.6
92398.9
78222.8
68078.1
54899.9
37411.1
19568.1
16547.8
13919.8
11410.3
10699.3
10815
9785.8
7235.7
5202
4595.3
4529.9
4413.4
339.8
321
337.4
241.3
225.7

income-statement-row.row.cost-of-revenue

0230524.4201494.9187281.1
164474
159751.7
136521.5
114122.7
106530.9
92715.3
80994.1
67980.1
58792.6
46882.2
30619.9
17851.8
15101.4
12697.8
10618.3
9997.3
9794
8774.9
6215.3
4491.7
4003.8
3970
3886.7
291.8
270.4
291.9
205.8
193.8

income-statement-row.row.gross-profit

029032.630486.428543.1
27435.2
26814.1
22562.9
16724.5
14233.8
12801.3
11404.8
10242.7
9285.5
8017.7
6791.1
1716.3
1446.4
1222
792
702
1020.9
1010.9
1020.3
710.3
591.5
559.9
526.7
48
50.6
45.5
35.4
31.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-31012.4-267.7
117.6
174.1
144.3
-23.3
484.6
522.9
547.9
185.2
271.6
187.7
183.6
-12.3
39.8
25.2
43.9
61
69.6
55.1
36.6
7.6
9.3
9.6
22
22.7
-0.3
0.4
1.4
0.7

income-statement-row.row.operating-expenses

020837.521705.420616.2
19297.4
18884.5
16326.3
11747
9972.3
8846.1
8010.4
7341
6617.6
5584.3
4909.4
1112.4
1095.3
956.4
630
632
925.2
850.3
843.1
544.3
413.1
379.3
380.5
20.4
20.8
15.6
9.1
6.6

income-statement-row.row.cost-and-expenses

0251361.9223200.3207897.3
183771.4
178636.2
152847.7
125869.7
116503.2
101561.4
89004.5
75321.1
65410.2
52466.5
35529.4
18964.2
16196.7
13654.2
11248.2
10629.3
10719.2
9625.1
7058.5
5036
4416.9
4349.3
4267.2
312.2
291.2
307.5
214.9
200.4

income-statement-row.row.interest-income

0-461.8438.3338.2
288.3
234
197.4
161.4
172
138
207
242.1
304.4
262.9
47.2
10.6
8.4
20.8
18.5
19.7
23.4
15.5
7.8
8.2
17.6
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

018851689.31518.2
1411.9
1405.2
1204.4
875.7
645.1
613.3
584.9
413.7
472.4
461.8
213.5
113.2
156.5
141.7
127.3
47.8
36.4
52.1
30.6
13.4
55
48.3
63.7
20.9
12
8.9
3.9
2.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1270.2-206.3-61.7
-8.9
48.5
135
-23.3
431.9
485.2
530.2
186.5
291.8
161.4
96
-15.8
23.1
23.9
16.9
37.5
40.7
38.4
21.9
-1
3.8
0.4
19.6
-1
-0.2
0.2
1.2
-0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-31012.4-267.7
117.6
174.1
144.3
-23.3
484.6
522.9
547.9
185.2
271.6
187.7
183.6
-12.3
39.8
25.2
43.9
61
69.6
55.1
36.6
7.6
9.3
9.6
22
22.7
-0.3
0.4
1.4
0.7

income-statement-row.row.total-operating-expenses

0-1270.2-206.3-61.7
-8.9
48.5
135
-23.3
431.9
485.2
530.2
186.5
291.8
161.4
96
-15.8
23.1
23.9
16.9
37.5
40.7
38.4
21.9
-1
3.8
0.4
19.6
-1
-0.2
0.2
1.2
-0.2

income-statement-row.row.interest-expense

018851689.31518.2
1411.9
1405.2
1204.4
875.7
645.1
613.3
584.9
413.7
472.4
461.8
213.5
113.2
156.5
141.7
127.3
47.8
36.4
52.1
30.6
13.4
55
48.3
63.7
20.9
12
8.9
3.9
2.9

income-statement-row.row.depreciation-and-amortization

02361.22222.42139.8
2137.8
1885
1169.5
840
746.1
672.6
585
549.7
536.6
479.2
382.7
93.2
94.2
96.4
69.1
59.1
74.2
70.3
72.3
50.4
50.1
43.4
21.4
-3
11.7
8.5
3.3
1.6

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

08195.19014.78205.5
7184.4
6213.9
5208.3
5228.2
4207.1
3686.6
3269.5
3074.3
2795.9
2873.7
2076.6
370.7
163.6
122.6
84.6
61.2
150.1
219.5
191.6
203.3
218.4
137.5
89.9
30.6
18.1
21.4
23
23.7

income-statement-row.row.income-before-tax

069258808.48143.8
7175.5
6262.5
5343.4
5204.8
4639
4171.9
3799.7
3260.8
3087.7
3035.1
2172.5
355
186.7
146.6
101.5
98.7
190.8
257.9
213.5
202.3
222.3
137.9
109.6
29.7
17.9
21.6
24.2
23.4

income-statement-row.row.income-tax-expense

01887.71816.31869.2
1570.2
1431.7
887.1
1147
809.3
807.5
807.7
634.2
627.1
589.1
393.6
91.5
57.3
51.1
40.3
25.9
52.3
50.4
50.3
27.6
17.6
27.1
19.8
1
2.6
3.2
3.6
3.6

income-statement-row.row.net-income

037685617.25093.5
4496.2
4081
3881.1
3520.6
3196.4
2877
2591.1
2242.9
2052.9
2042.2
1368.3
173.3
82
66.3
68.7
50.5
93.1
154.4
125.8
145.3
184.8
94.4
78.7
28.7
15.2
18.3
20.6
19.9
类似股票
您可能还对以下内容感兴趣：
ITNS
Itonis, Inc..
0.0009 USD
PNK
2192.HK
Medlive Technology Co., Ltd..
8.53 HKD
HKSE
PDCO
Patterson Companies, Inc..
26.3 USD
NASDAQ
7459.T
MediPal Holdings Corporation.
2488.5 JPY
JPX
MEDOF
Medios AG.
13.64 USD
PNK
UPR.L
Uniphar plc.
220 GBp
LSE
EPMT.JK
PT Enseval Putera Megatrading Tbk..
2420 IDR
JKT
SNYR
Synergy CHC Corp..
0.01 USD
OTC
EBO.AX
EBOS Group Limited.
31.73 AUD
ASX
9265.T
Yamashita Health Care Holdings,Inc..
2765 JPY
JPX

常见问题

什么是 Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) 总资产是多少？

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) 总资产为 211972533766.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.113.

什么是公司自由现金流？

自由现金流为 -0.102.

什么是企业净利润率？

净利润率为 0.014.

企业总收入是多少？

总收入为 0.028.

什么是 Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 3767999581.000.

公司总债务是多少？

债务总额为 58553624884.000.

营业费用是多少？

运营支出为 20837465592.000.

公司现金是多少？

企业现金为 0.000.